Evidence map›Paper›PMID 9305652›Full record

ArticleThe EMBO journal1997

Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.

X Wu, H Liu, H Xiao, J A Conway, E Hunter, J C Kappes

Abstract read
In one paragraph

Article in The EMBO journal, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. HIV-1 Vpr-a still "enigmatic multitasker".Frontiers in microbiology · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Virological and cellular roles of the transcriptional coactivator LEDGF/p75.Current topics in microbiology and immunology · 2009
    Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

X WuDepartment of Medicine, University of Alabama at Birmingham, 35294, USA.
H Liu
H Xiao
J A Conway
E Hunter
J C Kappes

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
FUNCTIONAL ANALYSIS OF THE HIV-2 VPX AND VPR GENESR29AI031816 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KAPPES, JOHN C · 1991 to 1995
–
NIAID NIH HHS AI31816NIAID NIH HHS P30-AI-27767
6 · The paper itself

Abstract

The expression and incorporation of retroviral enzymes into virions in the form of Gag/Pol precursor polyproteins is believed to be important for the assembly of infectious viral particles. HIV-1 encodes a 160 kDa Gag/Pol precursor that includes Gag, protease (PR), reverse transcriptase (RT) and integrase (IN). We have developed the use of HIV accessory proteins (Vpr and Vpx) as vehicles to incorporate protein of both viral and non-viral origin into virions by expression in trans as heterologous fusion proteins (Wu et al., 1995, 1996a). To analyze the role of Gag/Pol in the formation of infectious virions, we incorporated RT and IN into HIV-1 particles in trans, as fusion partners of viral protein R (Vpr). Virions derived from an RT and IN minus proviral clone were infectious and replicated through a complete cycle of infection when RT and IN proteins were provided in trans. These results demonstrate that functional RT and IN proteins can be provided in trans, and that their expression and incorporation into virions as components of Gag/Pol are not required for the formation of infectious virions. Thus, for the first time, we have demonstrated for a human pathogenic retrovirus that processes of assembly and the function of critical viral enzymes can be unlinked. This finding will provide unique opportunities to explore retroviral RT/IN function and the role of Gag/Pol in the formation of infectious virions in the context of a replicating virus (in vivo).

Indexed as

Blotting, WesternCell Linegag Gene Products, Human Immunodeficiency VirusGene Expression Regulation, ViralGene Products, gagGene Products, vprGenetic Complementation TestHeLa CellsHIV-1HIV IntegraseHIV Reverse TranscriptaseHumansMutationpol Gene Products, Human Immunodeficiency VirusProtein PrecursorsRecombinant Fusion Proteinsgag Gene Products, Human Immunodeficiency VirusGene Products, gagGene Products, vprHIV IntegraseHIV Reverse Transcriptasepol Gene Products, Human Immunodeficiency Viruspr160 gag-pol precursor protein, Human immunodeficiency virus 1Protein PrecursorsRecombinant Fusion ProteinsRetroviridae ProteinsViral Regulatory and Accessory Proteinsvpr Gene Products, Human Immunodeficiency VirusVPX protein, Human immunodeficiency virus 2

Identifiers

PMID9305652
PMCPMC1170145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.